Clinical Trials Logo

Mucositis clinical trials

View clinical trials related to Mucositis.

Filter by:

NCT ID: NCT06455306 Recruiting - Clinical trials for Peri-implant Mucositis

Erythritol Air Polishing in Mucositis Treatment

Start date: March 18, 2024
Phase: N/A
Study type: Interventional

This study aimed to evaluate the effectiveness of air polishing systems compared to the exclusive use of oral hygiene instruction in the treatment of peri-implant mucositis

NCT ID: NCT06452979 Recruiting - Clinical trials for Obstructive Sleep Apnea

Mucosal Inflammation in Children With OSA

Start date: January 1, 2023
Phase:
Study type: Observational
Read more »
NCT ID: NCT06450821 Not yet recruiting - Periodontitis Clinical Trials

PROSpECT-PRIOR-2-CHEMO: PRIOR Dental Intervention Before Chemo to Reduce Chemotherapy Complications

Start date: July 2024
Phase: N/A
Study type: Interventional

The aim of this feasibility trial is to determine if it is safe and feasible to treat oral health diseases in people with haematological cancers before they start their chemotherapy to reduce complications and disruption to planned chemotherapy dose or schedule.

NCT ID: NCT06449625 Not yet recruiting - Inflammation Clinical Trials

Semaglutide in Auto-HSCT

PROTECT
Start date: August 12, 2024
Phase: Phase 2
Study type: Interventional
Read more »
NCT ID: NCT06446180 Completed - Oral Mucositis Clinical Trials

Streptococcus Salivarius K12@Lip@GSH Alleviates Oral Mucositis in Patients Undergoing Radiotherapy

Start date: January 31, 2024
Phase: N/A
Study type: Interventional

Radiation-induced oral mucositis (RIOM) is the most common oral complication of cancer patients receiving radiotherapy and/or chemotherapy, leading to poor quality of life. the investigators previous studies that have reported the use of single SSK12 probiotics in RIOM. However, SSK12 probiotics alone may lack stability, free radical scavenging activity and oral local targeting.Here, the investigators designed a new oral probiotic K12@Lip@GSH that SSK12 is encapsulated in liposomes(Lip) to enhance its stability and free radical scavenging ability, and glutathione (GSH) transporter-mediated oral targeting agent based on the over-expression of GSH transporters at the RIOM. The investigators have complete evaluated the treatment outcome of SSK12@Lip@GSH on RIOM mice. The investigators designed a single-center, single-arm prospective clinical study to evaluate the efficacy and safety of SsK12@Lip@GSH in the treatment of radioactive oral mucositis in patients with head and neck malignancies

NCT ID: NCT06408467 Completed - Peri-Implantitis Clinical Trials

Monitoring of Non-Surgical Treatment of Peri-implantitis

Start date: January 1, 2022
Phase: N/A
Study type: Interventional

This study aimed to investigate the response to non-surgical treatment of peri-implantitis diseases during the maintenance phase. The patients underwent non-surgical implant maintenance treatment, and the success of the treatment was measured again after 30 days using the same criteria and methods.

NCT ID: NCT06392256 Recruiting - Clinical trials for Peri-implant Mucositis

Effect of Free Gingival Grafting on Peri-implant Health

Start date: February 1, 2024
Phase: N/A
Study type: Interventional
Read more »
NCT ID: NCT06390176 Recruiting - Oral Mucositis Clinical Trials

Lactobacillus Rhamnosus GG Alleviates Oral Mucositis in Patients Undergoing Radiotherapy

Start date: November 10, 2023
Phase: N/A
Study type: Interventional
Read more »
NCT ID: NCT06383351 Recruiting - Peri-Implantitis Clinical Trials

Patients' Illness Perception of Peri-implant Diseases. A Cross-sectional Study

Start date: April 16, 2024
Phase:
Study type: Observational

Despite extensive research on periodontitis, little attention has been given to the symptoms and perception of peri-implant diseases and their impact on oral health-related quality of life. The study aims to assess patient perception of these diseases and their impact on quality of life through a cross-sectional observational study. Patients will be recruited from the Unit of Periodontics at "Le Scotte" University Hospital and will undergo diagnosis followed by questionnaire assessments. No follow-up visits are planned, and validated questionnaires will be administered to evaluate perception and impact on quality of life. Study procedures will include recording biometric peri-implant parameters and administering questionnaires such as the Brief Illness Perception Questionnaire (BIPQ) and Oral Health Impact Profile-14 (OHIP-14).

NCT ID: NCT06381635 Recruiting - Radiation Mucositis Clinical Trials

Effect of Aloe Vera Gel and Manuka Honey on Radiation Induced Oral Mucositis

Start date: April 1, 2024
Phase: N/A
Study type: Interventional

The goal of this [ type of study: Clinical trial] is to test effectiveness of Aloe Vera Gel and Manuka Honey in management of Radiation Induced Mucositis in head and neck cancer patients. The main question [s] ] is to [ learn about, test, compare etc.] it aims to answer are: 1. Is Aloe Vera Gel and Manuka Honey effective in management of Radiation Induced Mucositis? 2. Does Aloe Vera Gel and Manuka Honey affect the level of TGFβ1 and EGF in saliva of patients with radiation induced mucositis? participants will be asked to apply Aloe Vera Gel and Manuka Honey or saline three times daily during radiotherapy and 6 months after radiotherapy.